MED Stock Summary and Trading Ideas (Medifast | NYSE:MED)

Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.

Medifast trades on the NYSE stock market under the symbol MED.

As of December 12, 2024, MED stock price declined to $20.15 with 145,314 million shares trading.

MED has a beta of -0.60, meaning it tends to be less sensitive to market movements. MED has a correlation of 0.02 to the broad based SPY ETF.

MED has a market cap of $220.39 million. This is considered a Small Cap stock.

Last quarter Medifast reported $140 million in Revenue and $.35 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.63.

In the last 3 years, MED traded as high as $222.00 and as low as $17.07.

The top ETF exchange traded funds that MED belongs to (by Net Assets): IWM, VTI, AVUV, VXF, IWN.

MED has underperformed the market in the last year with a return of -73.0%, while SPY returned +32.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MED shares. However, MED has outperformed the market in the last 3 month and 2 week periods, returning +10.4% and +3.7%, while SPY returned +9.3% and +0.9%, respectively. This indicates MED has been having a stronger performance recently.

MED support price is $20.20 and resistance is $21.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MED shares will trade within this expected range on the day.